Bone Biologics Corp (NASDAQ: BBLG)
$1.18
+0.0300 ( +2.61% ) 21.1K
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Market Data
Open
$1.18
Previous close
$1.15
Volume
21.1K
Market cap
$1.26M
Day range
$1.14 - $1.23
52 week range
$1.00 - $12.32
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 10, 2024 |
3 | Insider transactions | 1 | Jan 10, 2024 |
8-k | 8K-related | 15 | Jan 10, 2024 |
8-k | 8K-related | 13 | Jan 02, 2024 |
8-k | 8K-related | 16 | Dec 18, 2023 |
8-k | 8K-related | 13 | Dec 13, 2023 |
10-k/a | Quarterly Reports | 16 | Nov 20, 2023 |
def | Proxies and info statements | 3 | Nov 20, 2023 |
8-k | 8K-related | 19 | Nov 20, 2023 |
10-q | Quarterly Reports | 55 | Nov 14, 2023 |